PCI Biotech
CONTACT US
ABOUT PCI BIOTECH BOARD OF DIRECTORS MANAGEMENT COMPANY PRESENTATION
TECHNOLOGY PIPELINE PARTNERING
INVESTORS NEWS REPORTS AND PRESENTATIONS SHARE INFORMATION GENERAL MEETING INFORMATION FINANCIAL CALENDAR CORPORATE GOVERNANCE AND CSR NOMINATION COMMITTEE
ABOUT US ABOUT PCI BIOTECH BOARD OF DIRECTORS MANAGEMENT COMPANY PRESENTATION WHAT WE DO TECHNOLOGY PIPELINE PARTNERING INVESTORS INVESTORS NEWS REPORTS AND PRESENTATIONS SHARE INFORMATION GENERAL MEETING INFORMATION FINANCIAL CALENDAR CORPORATE GOVERNANCE AND CSR NOMINATION COMMITTEE CONTACT US
PCI Biotech
 

NEWS

News archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
 
PCI Biotech to present at Bio€quity Europe
NewsRonny SkuggedalMay 18, 2017
First quarter 2017 report and presentation
NewsRonny SkuggedalMay 16, 2017
Notice of Annual General Meeting 2017
NewsRonny SkuggedalMay 8, 2017
Invitation to first quarter 2017 presentation
NewsRonny SkuggedalMay 5, 2017
Employee share option scheme
NewsRonny SkuggedalMay 5, 2017
Annual Report 2016
NewsRonny SkuggedalApril 25, 2017
Presentation of fimaCHEM Phase I data in bile duct cancer at The International Liver Congress 2017
NewsRonny SkuggedalApril 21, 2017
PCI Biotech searching for Chief Medical Officer
NewsRonny SkuggedalApril 7, 2017
PCI Biotech to present clinical data on its phase I/II trial in bile duct cancer at The International Liver Congress 2017
NewsRonny SkuggedalApril 6, 2017
PCI Biotech to present at 5th Cancer BioPartnering & Investment Forum
NewsRonny SkuggedalMarch 28, 2017
PCI Biotech to present at Bio-Europe Spring 2017
NewsRonny SkuggedalMarch 22, 2017
PCI Biotech to present poster at 4th Immunotherapy of cancer conference
NewsRonny SkuggedalMarch 21, 2017
Fourth quarter and preliminary 2016 report and presentation
NewsRonny SkuggedalFebruary 28, 2017
Invitation to fourth quarter 2016 presentation
NewsRonny SkuggedalFebruary 20, 2017
PCI Biotech awarded NOK 13.8 million from The Research Council of Norway to further development of PCI for use in vaccination
NewsRonny SkuggedalJanuary 27, 2017
Capital increase registered and listing of new shares
NewsRonny SkuggedalJanuary 19, 2017
Final results of the rights issue
NewsRonny SkuggedalJanuary 10, 2017
PCI Biotech presentation from Biotech Showcase 2017
NewsRonny SkuggedalJanuary 10, 2017
The PCI Biotech and Ultimovacs collaboration awarded NOK 500,000 from Innovation Norway
NewsRonny SkuggedalJanuary 6, 2017
PCIB – preliminary results of the rights issue
NewsRonny SkuggedalJanuary 6, 2017
Newer Older

Privacy policy I Contact us
©COPYRIGHT PCI BIOTECH. ALL RIGHTS RESERVED